THERAPEUTIC CLASS
Tuberculosis
Tuberculosis remains the leading cause of death from an infectious disease among adults worldwide, with more than
10 million people becoming newly sick from tuberculosis each year. Advances in diagnosis, including the use of rapid
molecular testing and whole-genome sequencing in both sputum and non-sputum samples, could change this
situation. Although little has changed in the treatment of drug-susceptible tuberculosis, data on increased efficacy
with new and repurposed drugs have led WHO to recommend all-oral therapy for drug-resistant tuberculosis for the
first time ever in 2018.
No other version available